Novel conditioning regimen in upfront autologous stem cell transplantation in high-risk DLBCL

被引：0
|
作者：
Jiexian Ma
Shunrong Sun
Yingwei Hu
Min Wu
Lin Shen
Wulipan Fulati
Zilan Huang
Wensi Qian
Pingping Chen
Mingyue Chen
Yanhui Xie
机构：
[1] Huadong Hospital Affiliated with Fudan University,Department of Hematology
来源：
Bone Marrow Transplantation | 2022年 / 57卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1612 / 1614
页数：2
相关论文
共 50 条
  • [21] The role of upfront autologous stem cell transplantation in high-risk younger patients with primary central nervous system lymphoma
    Cho, Hyunsoo
    Chang, Jong Hee
    Kim, Yu Ri
    Kim, Soo-Jeong
    Chung, Haerim
    Park, Hyunsung
    Lee, Jung Yeon
    Jang, Ji Eun
    Kim, Yundeok
    Kim, Se Hoon
    Yang, Woo Ick
    Suh, Chang-Ok
    Cheong, June-Won
    Min, Yoo Hong
    Kim, Jin Seok
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 174 (03) : 444 - 453
  • [22] Myeloablative Conditioning Regimen in Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide in Children With High-risk Hematologic Malignancies
    Dufort y Alvarez, Gustavo
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2022, 44 (06) : E930 - E938
  • [23] Clofarabine and Total Body Irradiation as a Conditioning Regimen for Allogeneic Stem Cell Transplantation in High-Risk Acute Leukemia
    Atoui, Ali
    Dulery, Remy
    Terro, Khodr
    Abou Dalle, Iman
    Bazarbachi, Ali
    Mohty, Mohamad
    El Cheikh, Jean
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S432 - S432
  • [24] High Risk Multiple Myeloma: Better Outcomes with Upfront Tandem Autologous-Non-Myelo Ablative Allogeneic Stem Cell Transplantation Compared to Upfront Autologous Stem Cell Transplantation
    Nair, Anish Puliyayil
    Lee, Cindy
    Kalff, Anna
    Walker, Patricia A.
    Bergin, Krystal
    Hocking, Jay
    Morgan, Sue
    Klarica, Daniela
    Muirhead, Jenny
    Spencer, Andrew
    Lee, Oi Lin
    Horvath, Noemi
    BLOOD, 2016, 128 (22)
  • [25] MIDET plus Rituximab: An effective conditioning regimen for autologous stem cell transplantation (AST) in high-risk non-Hodgkin's lymphoma.
    Ballester, OF
    Jillella, A
    Raptis, A
    Hiemenz, J
    Wilcox, P
    Ustun, C
    Braun, B
    BLOOD, 2002, 100 (11) : 401B - 401B
  • [26] AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION IN HIGH-RISK MYELOMA
    MARIT, G
    BOIRON, JM
    REIFFERS, J
    BONE MARROW TRANSPLANTATION, 1990, 5 : 55 - 55
  • [27] Upfront autologous hematopoietic stem cell transplantation for high-risk patients with double-expressor diffuse large B cell lymphoma
    Yu Ri Kim
    Sun Och Yoon
    Soo-Jeong Kim
    June-Won Cheong
    Haerim Chung
    Jung Yeon Lee
    Ji Eun Jang
    Yundeok Kim
    Woo-Ick Yang
    Yoo Hong Min
    Jin Seok Kim
    Annals of Hematology, 2020, 99 : 2149 - 2157
  • [28] Autologous stem cell transplantation for high-risk neuroblastoma: the Iranian experience
    Hamidieh, A. A.
    Alimoghaddam, K.
    Huoseini, A.
    Jorjani, H.
    Jalali, A.
    Derakhshandeh, R.
    Ghavamzadeh, A.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S384 - S385
  • [29] Autologous stem cell transplantation for high-risk pediatric solid tumors
    JP Perentesis
    E Katsanis
    TE DeFor
    JP Neglia
    NKC Ramsay
    Bone Marrow Transplantation, 1999, 24 : 609 - 615
  • [30] Upfront autologous hematopoietic stem cell transplantation for high-risk patients with double-expressor diffuse large B cell lymphoma
    Kim, Yu Ri
    Yoon, Sun Och
    Kim, Soo-Jeong
    Cheong, June-Won
    Chung, Haerim
    Lee, Jung Yeon
    Jang, Ji Eun
    Kim, Yundeok
    Yang, Woo-Ick
    Min, Yoo Hong
    Kim, Jin Seok
    ANNALS OF HEMATOLOGY, 2020, 99 (09) : 2149 - 2157
12345